Cambridge - Healthtech › uploadedFiles › Conferences › CHI-Catalog...WORLD CONGRESS & May 17-19, 2016 Philadelphia Downtown Marriott Philadelphia, PA BiomarkerWorldCongress.com

Cambridge Healthtech InstituteYour Life Science Network

RESEARCH • COLLABORAT ION • ADVANCEMENT

Cambridge Innovation Institute

Conference & Course CatalogMarch – August 2016

CHI is a division of

2 | Cambridge Healthtech Institute

For over 20 years, Cambridge Healthtech Institute has developed more than 800 conferences, which have attracted over 60,000 attendees from around the world. CHI is the industry leader in offering quality programs that provide valuable new insights and competing points of view while offering balanced coverage of the latest developments in the life science industry. Leading researchers and business experts from top pharmaceutical, biotech, and academic organizations present their most current findings in a forum that features panel discussions and audience participation.

Each year, CHI organizes over 170 annual events geared to the biotech and pharmaceutical industries with specific focuses on Biomarkers, Genomics, Proteins and Proteomics, Drug Discovery & Development, IT and Informatics, Chemistry, Diagnostics & Safety, and Business.

For a comprehensive listing and detailed information about our products and services, please visit: healthtech.com.

About Cambridge Healthtech Institute

Follow us

TABLE OF CONTENTS

CONFERENCE SERIESBiological Therapeutic Products ...................................................... 4Biomarkers and Diagnostics ........................................................... 4Bioprocess and Manufacturing ....................................................... 5Clinical Trials & Translational Medicine ............................................ 6Chemistry ....................................................................................... 6BioPharmaceutical Strategy ............................................................ 6Drug Discovery & Development ..................................................... 7Drug Targets .................................................................................... 7Genomics ........................................................................................ 8Healthcare ....................................................................................... 8Informatics and IT ........................................................................... 9Therapeutic Indications ................................................................... 9Technology and Tools for Life Sciences ..........................................10

CONFERENCES BY DATE WITH DETAIL ....................................11-13

SHORT COURSE SCHEDULE .................................................... 14-15

CUSTOMER SERVICEPamela GerardiDirector of Customer ServiceE: [email protected] | T: 781-972-5409

Kris WatermanSr. Customer Service RepresentativeE: [email protected] | T: 781-972-5413

Rose LaRaiaCustomer Service RepresentativeE: [email protected] | T: 781-972-5400

MARKETINGJim MacNeilVice President of MarketingE: [email protected] | T: 781-972-5441

Rich HandySenior Director of MarketingE: [email protected] | T: 781-972-5456

SPONSOR & EXHIBIT SALESAngela ParsonsVice President of Business DevelopmentE: [email protected] | T: 781-972-5467

Carol DinersteinDirector, Business DevelopmentE: [email protected] | T: 781-972-5471

GROUP SALES David CunninghamDirector, Inside SalesE: [email protected] | T: 781-972-5472

GRAPHICSThomas NortonDesign DirectorE: [email protected] | T: 781-972-5440

PRODUCTIONEdel O’ Regan, Ph.D.Vice President of ProductionE: [email protected] | T: 781-972-5423

Christina LinghamExecutive Director of ConferencesE: [email protected] | T: 781-972-5464

Mary Ann BrownExecutive Director of ConferencesE: [email protected] | T: 781-972-5497

Julia Boguslavsky Executive Director of ConferencesE: [email protected] | T: 760-732-3139

Micah LiebermanExecutive Director of ConferencesE: [email protected] | T: 541-482-4709

CONTACT US

@CHI_Healthtech

linkedin.com/company/cambridge-healthtech-institute

youtube.com/user/cambridgehealthtech

Cambridge Healthtech Institute 250 First Avenue, Suite 300 | Needham, MA 02494

T: (781) 972-5400 or Toll-free in the U.S. 888-999-6288

F: (781) 972-5425

March – August 2016 | 3

2016 KEY EVENTS

The Protein Science Week

January 18-22, 2016Town and Country Resort & Convention CenterSan Diego, CACHI-PepTalk.com

April 5-7, 2016Seaport World Trade CenterBoston, MABio-ITWorldExpo.com

BIOMARKERS DIAGNOSTICSW O R L D C O N G R E S S

&

May 17-19, 2016Philadelphia Downtown MarriottPhiladelphia, PABiomarkerWorldCongress.com

August 23-26, 2016Grand Hyatt WashingtonWashington, DCNextGenerationDx.com

Summit for Clinical Trials Ops Executives

February 23-25, 2016Hyatt Regency MiamiMiami, FLSCOPESummit.com

Drug Discovery ChemistryApril 19-22, 2016Hilton San Diego ResortSan Diego, CADrugDiscoveryChemistry.com

June 14-17, 2016Westin Boston WaterfrontBoston, MAWorldPreclinicalCongress.com

September 19-22Westin Boston WaterfrontBoston, MADiscoveryonTarget.com

March 6-11, 2016Moscone North Convention CenterSan Francisco, CATriConference.com

The Essential Protein Engineering SummitBOSTON

April 25-29, 2016Seaport World Trade CenterBoston, MAPEGSummit.com

THE BIOPROCESSING SUMMIT

August 15-19, 2016Westin Boston WaterfrontBoston, MABioprocessingSummit.com

The Essential Protein Engineering SummitEUROPE

October 31-November 4, 2016EPIC SANA Lisboa HotelLisbon, PortugalPEGSummitEurope.com

ONE STOP SHOP AFFILIATED REPORTSCOLLECTION

for Over 1,000 Life Science Reports Spanning over 50 Research Areas

Insight Pharma Reports offers:

4 Market Data4 Pipeline Data4 Clinical Trial Data

4 Market Research4 Custom Reports4 Bundled Report Packages

For more information, contact Daniel Miller at: [email protected] or call (781) 972-5492

InsightPharmaReports.com

Just some of the Reports Available Include:

• Alzheimer’s Disease• Biomarkers & Diagnostics• BioPharma Strategy• Biosimilars & Generic Markets• Cancer Research and Therapeutics• Chemistry• Clinical Trials & Translational

• Medicine• Data Mining• Drug Discovery & Development• Health IT• Infectious Disease• Medical Devices• Multiple Sclerosis• Ocular• Pain Management• Pharmaceutical Marketing• Sequencing• Vaccines

...and many others

An Essential Collection of Timely & Concise Reports Analyzing the Technologies, Markets, and Strategic Issues Driving R&D Productivity. Available through Insight Pharma Reports and our Network of Affiliated Reports.


Conferences by Series

Biological Therapeutic Products

Predictive Preclinical Models in OncologyMarch 7-9, 2016 • San Francisco, CA

Biomarkers for Cancer ImmunotherapyMarch 10-11, 2016 • San Francisco, CA

Cancer BiotherapeuticsMarch 14-16, 2016 • Boston, MA

Immuno-OncologyMarch 14-15, 2016 • London, UK

Novel Approaches for Cancer March 15-16, 2016 • London, UK

Developability and Candidate SelectionMarch 14-15, 2016 • Bethesda, MD

Advances in Characterization Methods and Approaches March 16-17, 2016 • Bethesda, MD

Comparability and BiosimilarityMarch 17-18, 2016 • Bethesda, MD

PEGS China Summit April 5-7, 2016 • Pudong Shanghai

Protein and Antibody Engineering April 5-6, 2016 • Pudong Shanghai

Analytical Characterization and BiotherapeuticsApril 5-6, 2016 • Pudong Shanghai

Next-Generation Cancer BiotherapeuticsApril 6-7, 2016 • Pudong Shanghai

Clinical Development and Regulatory RequirementsApril 6-7, 2016 • Pudong Shanghai

Protein Aggregation and Stability April 6-7, 2016 • Pudong Shanghai

Clinical and Regulatory Strategies for Domestic and Global IND and BLA Filings April 6-7, 2016 • Pudong Shanghai

Drug Discovery ChemistryApril 19-22, 2016 • San Diego, CA

Phage and Yeast Display of AntibodiesApril 25-26, 2016 • Boston, MA

Difficult to Express ProteinsApril 25-26, 2016 • Boston, MA

Biologics for Autoimmune Diseases April 25-26, 2016 • Boston, MA

Characterization of BiotherapeuticsApril 25-26, 2016 • Boston, MA

Antibodies for Cancer TherapyApril 25-26, 2016 • Boston, MA

Immunogenicity: Regulatory and Clinical Case StudiesApril 25-26, 2016 • Boston, MA

Preventing Toxicity in Immunotherapy April 25-26, 2016 • Boston, MA

Fusion Protein TherapeuticsApril 25-26, 2016 • Boston, MA

Biophysical Analysis of BiotherapeuticsApril 27-28, 2016 • Boston, MA

Strategies for Immunogenicity Assay AssessmentApril 27-28, 2016 • Boston, MA

Antibody-Drug Conjugates I: New Ligands, Payloads and Alternative Formats April 27-28, 2016 • Boston, MA

Advancing Bispecific Antibodies and Combination Therapy to the Clinic April 27-28, 2016 • Boston, MA

Adoptive T Cell TherapyApril 27-28, 2016 • Boston, MA

Biologics and Vaccines for Infectious DiseasesApril 27-28, 2016 • Boston, MA

Protein Aggregation and Stability in BiopharmaceuticalsApril 28-29, 2016 • Boston, MAEngineering Bispecific AntibodiesApril 28-29, 2016 • Boston, MA

Agonist Immunotherapy Targets April 28-29, 2016 • Boston, MA

Antibody-Drug Conjugates II: Advancing Toward the ClinicApril 28-29, 2016 • Boston, MA

Optimizing Bioassays for BiologicsApril 28-29, 2016 • Boston, MA

Cancer Immunotherapy and CombinationsJune 15-16, 2016 • Boston, MA

Blood-Brain BarrierJune 15-16, 2016 • Boston, MA

Targeting Membrane ProteinsJune 16-17, 2016 • Boston, MA

Tumor Models for Cancer ImmunotherapyJune 16-17, 2016 • Boston, MA

Rapid Methods to Assess Quality and Stability of Biologics August 15-16, 2016 • Boston, MA

Cell Therapy CMC, Quality and AnalyticsAugust 15-16, 2016 • Boston, MA

Early Analytical Development for Biotherapeutics August 17-18, 2016 • Boston, MA

Cell Therapy Bioproduction, Operations and Logistics August 17-18, 2016 • Boston, MA

High-Concentration Protein Formulations August 18-19, 2016 • Boston, MA

Process Characterization, Qualification and Control August 18-19, 2016 • Boston, MA

Gene Therapy BioproductionAugust 18-19, 2016 • Boston, MA

Diagnostics to Guide Cancer Immunotherapy August 24-25, 2016 • Washington, DC

Molecular Medicine Tri-ConMarch 6-11, 2016 • San Francisco, CA

PCR for Molecular Medicine March 7-9, 2016 • San Francisco, CA

Genomic Sample Prep and Biomarker Assay DevelopmentMarch 7-9, 2016 • San Francisco, CA

Digital PathologyMarch 7-9, 2016 • San Francisco, CA

Molecular DiagnosticsMarch 7-9, 2016 • San Francisco, CA

Precision MedicineMarch 7-9, 2016 • San Francisco, CA

Molecular Diagnostics for Infectious DiseaseMarch 7-9, 2016 • San Francisco, CA

Personalized DiagnosticsMarch 7-9, 2016 • San Francisco, CA

Cancer Molecular MarkersMarch 7-9, 2016 • San Francisco, CA

Circulating Tumor CellsMarch 7-9, 2016 • San Francisco, CA


Circulating Cell-Free DNAMarch 10-11, 2016 • San Francisco, CA

Companion DiagnosticsMarch 10-11, 2016 • San Francisco, CA


Conferences by SeriesPoint-of-Care DiagnosticsMarch 10-11, 2016 • San Francisco, CA


Commercialization of Molecular DiagnosticsMarch 10-11, 2016 • San Francisco, CA

microRNA as Biomarkers and DiagnosticsApril 4-5, 2016 • Cambridge, MA

Molecular Diagnostics EuropeApril 4-7, 2016 • Lisboa, Portugal

Advances in Prenatal Molecular DiagnosticsApril 4-6, 2016 • Lisboa, Portugal

Circulating Tumour CellsApril 5-6, 2016 • Lisboa, Portugal

Circulating Cell-Free DNAApril 6-7, 2016 • Lisboa, Portugal

Reproductive Genetic DiagnosticsApril 6-7, 2016 • Lisboa, Portugal

Point-of-Care DiagnosticsApril 6-7, 2016 • Lisboa, Portugal

Extracellular RNA in Drug and Diagnostic DevelopmentApril 5-6, 2016 • Cambridge, MA

Bio-IT WorldApril 5-7, 2016 • Boston, MA

BioinformaticsApril 5-7, 2016 • Boston, MA

Exosomes and Microvesicles as Biomarkers and DiagnosticsMay 16, 2016 • Philadelphia, PA

Biomarkers & Diagnostics World CongressMay 17-19, 2016 • Philadelphia, PA

Big Data for Personalized Medicine and Biomarker DiscoveryMay 17-18, 2016 • Philadelphia, PA

Cell-Free Biomarkers and DiagnosticsMay 17-18, 2016 • Philadelphia, PA

Biomarkers for Patient SelectionMay 17-18, 2016 • Philadelphia, PA

Clinical and Translational Biomarkers in Drug DevelopmentMay 18-19, 2016 • Philadelphia, PA

Companion DiagnosticsMay 18-19, 2016 • Philadelphia, PA

Biomarkers for Cancer ImmunotherapyMay 18-19, 2016 • Philadelphia, PA

Latest Advances in Nano-OncologyJune 14, 2016 • Boston, MA

Applying Pharmacology to New Drug DevelopmentJune 15, 2016 • Boston, MA

Novel Preclinical Models in OncologyJune 15-16, 2016 • Boston, MA

Tumor Models for Cancer ImmunotherapyJune 16-17, 2016 • Boston, MA

The Liquid Biopsy SummitJune 22-24, 2016 • San Francisco, CA

Biodefense World SummitJune 27-30, 2016 • Baltimore, MD

Next Generation Dx Summit August 23-26, 2016 • Washington, DC

Enabling Point-of-Care Diagnostics August 23-24, 2016 • Washington, DC

Companion Diagnostics: Strategy and Partnerships August 23-24, 2016 • Washington, DC

Coverage and Reimbursement of Advanced Diagnostics August 23-24, 2016 • Washington, DC

Clinical NGS Assays August 23-24, 2016 • Washington, DC

Circulating Tumor CellsAugust 23-24, 2016 • Washington, DC

DNA Forensics August 23-24, 2016 • Washington, DC

Hospital Laboratory Design and Renovation August 23-24, 2016 • Washington, DC

Molecular Diagnostics for Infectious Disease August 24-25, 2016 • Washington, DC


Commercialization of Molecular Diagnostics August 24-25, 2016 • Washington, DC

Clinical Application of Cell-Free DNA August 24-25, 2016 • Washington, DC

Leveraging Pharmacies for Rapid Diagnostics August 24-25, 2016 • Washington, DC

NGS Diagnostics: Data Considerations, Annotation and Interpretation August 24-25, 2016 • Washington, DC

Predictive Cancer Biomarkers August 26, 2016 • Washington, DC

Non-Invasive Prenatal Testing August 26, 2016 • Washington, DC

Health and Wellness Genomic Screening August 26, 2016 • Washington, DC

Advances in Microbiome Diagnostics August 26, 2016 • Washington, DC

Digital PCR August 26, 2016 • Washington, DC

Biotherapeutics Analytical SummitMarch 14-18, 2016 • Bethesda, MD

Difficult to Express ProteinsApril 25-26, 2016 • Boston, MA

Characterization of BiotherapeuticsApril 25-26, 2016 • Boston, MA

Immunogenicity: Regulatory and Clinical Case StudiesApril 25-26, 2016 • Boston, MABiophysical Analysis of BiotherapeuticsApril 27-28, 2016 • Boston, MA

Strategies for Immunogenicity Assay AssessmentApril 27-28, 2016 • Boston, MA

Protein Aggregation and Stability in BiopharmaceuticalsApril 28-29, 2016 • Boston, MA

Optimizing Bioassays for BiologicsApril 28-29, 2016 • Boston, MA

Protein Expression System EngineeringApril 28-29, 2016 • Boston, MA

The Bioprocessing SummitAugust 15-19, 2016 • Boston, MA

Optimizing Cell Culture Technology August 15-16, 2016 • Boston, MA

Rapid Methods to Assess Quality and Stability of Biologics August 15-16, 2016 • Boston, MA

Continuous Processing in Biopharm Manufacturing August 15-16, 2016 • Boston, MA

Cell Therapy CMC, Quality and Analytics August 15-16, 2016 • Boston, MA

Host Cell Proteins: Detection, Analysis and Removal August 15-16, 2016 • Boston, MA

Manufacturing and CMC Strategies for Biologics August 15-16, 2016 • Boston, MA

Overcoming Formulation Challenges for Biopharmaceutical Development August 17-18, 2016 • Boston, MA

Bioproduction: Scale, Bioreactors and Disposables August 17-18, 2016 • Boston, MA

Early Analytical Development for Biotherapeutics August 17-18, 2016 • Boston, MA

Advances in Purification Technologies August 17-18, 2016 • Boston, MA


Conferences by SeriesCell Therapy Bioproduction, Operations and Logistics August 17-18, 2016 • Boston, MA

Virus and Pathogen Clearance and Safety in Biologics August 18-19, 2016 • Boston, MA

Optimizing Cell Line Development August 18-19, 2016 • Boston, MA

High-Concentration Protein Formulations August 18-19, 2016 • Boston, MA

Process Characterization, Qualification and Control August 18-19, 2016 • Boston, MA

Gene Therapy Bioproduction August 18-19, 2016 • Boston, MA

Genomic Sample Prep and Biomarker Assay Development March 7-9, 2016 • San Francisco, CA

Cancer ImmunotherapyMarch 7-9, 2016 • San Francisco, CA



Cancer BiotherapeuticsMarch 14-16, 2016 • London, UK

Advanced Diagnostics for Infectious DiseaseApril 5-6, 2016 • Lisboa, Portugal

Medical Informatics World ConferenceApril 4-5, 2016 • Boston, MA

BioIT WorldApril 5-7, 2016 • Boston, MA

Clinical Research & Translational InformaticsApril 5-7, 2016 • Boston, MA

Cancer InformaticsApril 5-7, 2016 • Boston, MA

PEGS China SummitApril 5-7, 2016 • Pudong Shanghai




CHI’s Clinical Trial Innovation SummitMay 9-11, 2016 • Boston, MA

Mastering Risk-Based MonitoringMay 9-10, 2016 • Boston, MA

Big Data for Clinical TrialsMay 9-10, 2016 • Boston, MA

Patient Recruitment & Site SelectionMay 9-10, 2016 • Boston, MA

Clinical Trial AuditingMay 10-11, 2016 • Boston, MA

Outsourcing for Clinical TrialsMay 10-11, 2016 • Boston, MA

Data & Tech Driven Clinical Trials May 10-11, 2016 • Boston, MA



Biomarkers for Patient Selection May 17-18, 2016 • Philadelphia, PA


Biomarkers for Cancer Immunotherapy May 18-19, 2016 • Philadelphia, PA



Companion Diagnostics: Strategy and PartnershipsAugust 23-24, 2016 • Washington, DC


Bio-IT WorldApril 5-7, 2016 • Boston, MA


Inflammation InhibitorsApril 19-20, 2016 • San Diego, CA

Protein-Protein InteractionsApril 19-20, 2016 • San Diego, CA

Epigenetic Inhibitor DiscoveryApril 19-20, 2016 • San Diego, CA

Fragment-Based Drug DiscoveryApril 20-21, 2016 • San Diego, CA

Kinase Inhibitor ChemistryApril 20-21, 2016 • San Diego, CA

Macrocyclics and Constrained PeptidesApril 20-21, 2016 • San Diego, CA

Antivirals: Small Molecules against Viral and Host TargetsApril 22, 2016 • San Diego, CA

Biophysical Approaches for Drug DiscoveryApril 22, 2016 • San Diego, CA

Brain Penetrant InhibitorsApril 22, 2016 • San Diego, CA

PEGS: The Essential Protein Engineering SummitApril 25-29, 2016 • Boston, MA

Mastering Medicinal ChemistryJune 15-16, 2016 • Boston, MA

Chemical Biology in Drug DiscoveryJune 16-17, 2016 • Boston, MA

Property-Based Drug Design in Medicinal ChemistryJune 16-17, 2016 • Boston, MA

Commercialization of Molecular DiagnosticsMarch 10-11, 2016 • San Francisco, CA

Pharmaceutical R&D InformaticsApril 5-7, 2016 • Boston, MA

Clinical Development and Regulatory Requirements April 6-7, 2016 • Pudong Shanghai


Outsourcing for Clinical TrialsMay 10-11, 2016 • Boston, MA

Strategic Alliance Management CongressMay 16-18, 2016 • Philadelphia, PA

Companion DiagnosticsMay 18-19, 2016 • Philadelphia, PA


Conferences by SeriesCompanion Diagnostics: Strategy and Partnerships August 23-24, 2016 • Washington, DC


Commercialization of Molecular Diagnostics August 24-25, 2016 • Washington, DC




New Frontiers in Gene Editing March 10-11, 2016 • San Francisco, CA

Immuno-Oncology March 14-15, 2016 • London, UK

Novel Approaches for CancerMarch 15-16, 2016 • London, UK


Oligonucleotide Therapeutics and Delivery April 4-5, 2016 • Cambridge, MA


BioIT WorldApril 5-7, 2016 • Boston, MA

Pharmaceutical R&D InformaticsApril 5-7, 2016 • Boston, MA




Protein-Protein InteractionsApril 19-20, 2016 • San Diego, CA

Epigenetic Inhibitor Discovery April 19-20, 2016 • San Diego, CA


Kinase Inhibitor ChemistryApril 20-21, 2016 • San Diego, CA






Biologics for Autoimmune DiseasesApril 25-26, 2016 • Boston, MA

Preventing Toxicity in ImmunotherapyApril 25-26, 2016 • Boston, MA

Fusion Protein TherapeuticsApril 25-26, 2016 • Boston, MA

Adoptive T Cell Therapy April 27-28, 2016 • Boston, MA

Biologics and Vaccines for Infectious DiseasesApril 27-28, 2016 • Boston, MA

Agonist Immunotherapy TargetsApril 28-29, 2016 • Boston, MA


Biomarkers & Diagnostics World Congress May 17-19, 2016 • Philadelphia, PA

Cell-Free Biomarkers and Diagnostics May 17-18, 2016 • Philadelphia, PA

Biomarkers for Patient SelectionMay 17-18, 2016 • Philadelphia, PA


Biomarkers for Cancer ImmunotherapyMay 18-19, 2016 • Philadelphia, PA

World Preclinical Congress June 14-17, 2016 • Boston, MA


Novel Preclinical Models in Oncology June 15-16, 2016 • Boston, MA

Applying Pharmacology to New Drug DevelopmentJune 15, 2016 • Boston, MA

New Approaches for Predicting Drug Toxicity June 15-16, 2016 • Boston, MA

Mastering Medicinal ChemistryJune 15-16, 2016 • Boston, MA


Advances in iPS Cell Technology for Drug Development ApplicationsJune 15-16, 2016 • Boston, MA

Blood-Brain Barrier June 15-16, 2016 • Boston, MA

3D Cellular Models June 16-17, 2016 • Boston, MA


Chemical Biology in Drug Discovery June 16-17, 2016 • Boston, MA

Tumor Models for Cancer Immunotherapy June 16-17, 2016 • Boston, MA

Property-Based Drug Design in Medicinal Chemistry June 16-17, 2016 • Boston, MA

Translational Gene Editing June 16-17, 2016 • Boston, MA

Companion Diagnostics: Strategy and Partnerships August 23-24 2016 • Washington, DCDiagnostics to Guide Cancer ImmunotherapyAugust 24-25, 2016 • Washington, DC

Drug TargetsSERIES


New Frontiers in Gene EditingMarch 10-11, 2016 • San Francisco, CA


Protein and Antibody EngineeringApril 5-6, 2016 • Pudong Shanghai




Protein Aggregation and StabilityApril 6-7, 2016 • Pudong Shanghai



Conferences by SeriesDrug Discovery ChemistryApril 19-22, 2016 • San Diego, CAInflammation Inhibitors April 19-20, 2016 • San Diego, CA

Protein-Protein Interactions April 19-20, 2016 • San Diego, CA

Epigenetic Inhibitor DiscoveryApril 19-20, 2016 • San Diego, CA


Kinase Inhibitor Chemistry April 20-21, 2016 • San Diego, CA
















Digital PathologyMarch 7-9, 2016 • San Francisco, CA

Cancer ImmunotherapyMarch 7-9, 2016 • San Francisco, CABioinformatics for Big DataMarch 7-9, 2016 • San Francisco, CA

Molecular DiagnosticsMarch 7-9, 2016 • San Francisco, CA

Personalized Diagnostics March 7-9, 2016 • San Francisco, CA

Cancer Molecular MarkersMarch 7-9, 2016 • San Francisco, CA


New Frontiers in Gene EditingMarch 10-11, 2016 • San Francisco, CA

Circulating Cell-Free DNA March 10-11, 2016 • San Francisco, CA

Companion DiagnosticsMarch 10-11, 2016 • San Francisco, CA

Genomics & Sequencing Data Integration, Analysis and VisualizationMarch 10-11, 2016 • San Francisco, CA


Circulating Tumour CellsApril 5-6, 2016 • Lisboa, Portugal

Circulating Cell-Free DNAApril 6-7, 2016 • Lisboa, Portugal

Reproductive Genetic DiagnosticsApril 6-7, 2016 • Lisboa, Portugal

Quantitative Imaging Radiomics and Advanced Medical Image AnalysisApril 4-5, 2016 • Boston, MA



Next-Gen Sequencing InformaticsApril 5-7, 2016 • Boston, MA

Clinical GenomicsApril 5-7, 2016 • Boston, MA



Biomarkers for Patient Selection May 17-18, 2016 • Philadelphia, PA


Advances in iPS Cell Technology for Drug Development ApplicationsJune 15-16, 2016 • Boston, MAChemical Biology in Drug DiscoveryJune 16-17, 2016 • Boston, MATranslational Gene EditingJune 16-17, 2016 • Boston, MA


Biodefense World SummitJune 27-30, 2016 • Baltimore, MD

DNA ForensicsAugust 23-24, 2016 • Washington, DC


Non-Invasive Prenatal Testing August 26, 2016 • Washington, DC

Health and Wellness Genomic Screening August 26, 2016 • Washington, DC


Digital Pathology March 7-9, 2016 • San Francisco, CA

Precision Medicine March 7-9, 2016 • San Francisco, CA



Value-Based Delivery Models and Cross-Industry Data Collaboration April 4-5, 2016 • Boston, MA

Coordinated Care, Patient Engagement and Connected HealthApril 4-5, 2016 • Boston, MA

Population Health Management Risk Modeling and Patient StratificationApril 4-5, 2016 • Boston, MA

Quantitative Imaging Radiomics and Advanced Medical Image AnalysisApril 4-5, 2016 • Boston, MA


Achieving Global Interoperability in Healthcare Datasets and SystemsApril 4-5, 2016 • Boston, MA

Data Visualization & Exploration Tools April 5-7, 2016 • Boston, MA


Hospital Laboratory Design and Renovation August 23-24, 2016 • Washington, DC

Telemedicine August 26, 2016 • Washington, DC

Integrated Informatics Driving Translational Research & Precision Medicine March 7-9, 2016 • San Francisco, CA

Bioinformatics for Big Data March 7-9, 2016 • San Francisco, CA

Precision MedicineMarch 7-9, 2016 • San Francisco, CA

Genomics & Sequencing Data Integration, Analysis and Visualization March 10-11, 2016 • San Francisco, CA


Value-Based Delivery Models and Cross-Industry Data Collaboration April 4-5, 2016 • Boston, MA

Coordinated Care, Patient Engagement and Connected Health April 4-5, 2016 • Boston, MA

Population Health Management Risk Modeling and Patient StratificationApril 4-5, 2016 • Boston, MA

Quantitative Imaging Radiomics and Advanced Medical Image Analysis April 4-5, 2016 • Boston, MA

Achieving Global Interoperability in Healthcare Datasets and Systems April 4-5, 2016 • Boston, MA

Bio-IT World April 5-7, 2016 • Boston, MA

Data & Storage ManagementApril 5-7, 2016 • Boston, MA

Software Applications & Services April 5-7, 2016 • Boston, MA

Data Computing April 5-7, 2016 • Boston, MA

Cloud Computing April 5-7, 2016 • Boston, MA


Next-Gen Sequencing Informatics April 5-7, 2016 • Boston, MA

Open Source InnovationsApril 5-7, 2016 • Boston, MA

Cancer InformaticsApril 5-7, 2016 • Boston, MA

Data SecurityApril 5-7, 2016 • Boston, MA

CHI’s Clinical Trial Innovation Summit May 9-11, 2016 • Boston, MA



Cell-Free Biomarkers and Diagnostics May 17-18, 2016 • Philadelphia, PA



TelemedicineAugust 26, 2016 • Washington, DC

SERIESCancer Immunotherapy March 7-9, 2016 • San Francisco, CA


Companion Diagnostics March 10-11, 2016 • San Francisco, CA

Immuno-Oncology March 14-15, 2016 • London, UK

Novel Approaches for Cancer March 15-16, 2016 • London, UK


Analytical Characterization and Biotherapeutics April 5-6, 2016 • Pudong Shanghai

Next-Generation Cancer Biotherapeutics April 6-7, 2016 • Pudong Shanghai


Protein Aggregation and StabilityApril 6-7, 2016 • Pudong Shanghai

Clinical and Regulatory Strategies for Domestic and Global IND and BLA FilingsApril 6-7, 2016 • Pudong Shanghai

Drug Discovery Chemistry April 19-22, 2016 • San Diego, CA


Antivirals: Small Molecules against Viral and Host Targets April 22, 2016 • San Diego, CA

Brain Penetrant Inhibitors April 22, 2016 • San Diego, CA

Biologics for Autoimmune Diseases April 25-26, 2016 • Boston, MA

Antibodies for Cancer Therapy April 25-26, 2016 • Boston, MA

Antibody-Drug Conjugates I: New Ligands, Payloads and Alternative Formats April 27-28, 2016 • Boston, MA

Advancing Bispecific Antibodies and Combination Therapy to the Clinic April 27-28, 2016 • Boston, MA

Adoptive T Cell Therapy April 27-28, 2016 • Boston, MA

Agonist Immunotherapy Targets April 28-29, 2016 • Boston, MA

Antibody-Drug Conjugates II: Advancing Toward the Clinic April 28-29, 2016 • Boston, MA

Biomarkers & Diagnostics World Congress May 17-19, 2016 • Philadelphia, PA

Biomarkers for Cancer Immunotherapy May 18-19, 2016 • Philadelphia, PA


Oncolytic Viruses in Cancer TherapiesJune 14, 2016 • Boston, MA

World Preclinical Congress June 14, 2016 • Boston, MA

Cancer Immunotherapy and Combinations June 15-16, 2016 • Boston, MA

Blood-Brain Barrier June 15-16, 2016 • Boston, MA




Targeting Membrane Proteins June 16-17, 2016 • Boston, MA


Molecular Medicine Tri-Con March 6-11, 2016 • San Francisco, CA



Cancer Immunotherapy March 7-9, 2016 • San Francisco, CA

Bioinformatics for Big Data March 7-9, 2016 • San Francisco, CA

Molecular Diagnostics March 7-9, 2016 • San Francisco, CA

Precision Medicine March 7-9, 2016 • San Francisco, CA

Personalized Diagnostics March 7-9, 2016 • San Francisco, CA

Cancer Molecular Markers March 7-9, 2016 • San Francisco, CA

Circulating Tumor Cells March 7-9, 2016 • San Francisco, CA

Clinical NGS Diagnostics March 7-9, 2016 • San Francisco, CA

Clinical NGS Diagnostics March 7-9, 2016 • San Francisco, CA


Point-of-Care Diagnostics March 10-11, 2016 • San Francisco, CA

Commercialization of Molecular Diagnostics March 10-11, 2016 • San Francisco, CA

Developability and Candidate Selection March 14-15, 2016 • Bethesda, MD

Advances in Characterization Methods and ApproachesMarch 16-17, 2016 • Bethesda, MD

Comparability and Biosimilarity March 17-18, 2016 • Bethesda, MD

microRNA as Biomarkers and Diagnostics April 4-5, 2016 • Cambridge, MA

Oligonucleotide Therapeutics and Delivery April 4-5, 2016 • Cambridge, MA

Circulating Tumour Cells April 5-6, 2016 • Lisboa, Portugal

Circulating Cell-Free DNA April 6-7, 2016 • Lisboa, Portugal


Bio-IT World April 5-7, 2016 • Boston, MA

Data & Storage Management April 5-7, 2016 • Boston, MA

Software Applications & Services April 5-7, 2016 • Boston, MA

Data Computing April 5-7, 2016 • Boston, MA

Cloud Computing April 5-7, 2016 • Boston, MA

Clinical Research & Translational Informatics April 5-7, 2016 • Boston, MA

Data Visualization & Exploration Tools April 5-7, 2016 • Boston, MA

Bioinformatics April 5-7, 2016 • Boston, MA

Next-Gen Sequencing Informatics April 5-7, 2016 • Boston, MA

Pharmaceutical R&D Informatics April 5-7, 2016 • Boston, MA

Open Source Innovations April 5-7, 2016 • Boston, MA

Cancer Informatics April 5-7, 2016 • Boston, MA

Data Security April 5-7, 2016 • Boston, MA




Protein Aggregation and Stability April 6-7, 2016 • Pudong Shanghai


Inflammation Inhibitors April 19-20, 2016 • San Diego, CA

Protein-Protein Interactions April 19-20, 2016 • San Diego, CA

Epigenetic Inhibitor Discovery April 19-20, 2016 • San Diego, CA

Fragment-Based Drug Discovery April 19-21, 2016 • San Diego, CA

Kinase Inhibitor Chemistry April 20-21, 2016 • San Diego, CA


Antivirals: Small Molecules against Viral and Host Targets April 22, 2016 • San Diego, CA

Biophysical Approaches for Drug Discovery April 22, 2016 • San Diego, CA

Brain Penetrant Inhibitors April 22, 2016 • San Diego, CA


Phage and Yeast Display of Antibodies April 25-26, 2016 • Boston, MA

Antibody-Drug Conjugates I: New Ligands, Payloads and Alternative FormatsApril 27-28, 2016 • Boston, MA


Protein Expression System Engineering April 28-29, 2016 • Boston, MA


Patient Recruitment & Site Selection May 9-10, 2016 • Boston, MA


Biomarkers & Diagnostics World Congress May 17-19, 2016 • Boston, MA

World Preclinical CongressJune 14-17, 2016 • Boston, MA


New Approaches for Predicting Drug Toxicity June 15-16, 2016 • Boston, MA

Cancer Immunotherapy and Combinations June 15-16, 2016 • Boston, MA

Advances in iPS Cell Technology for Drug Development Applications June 15-16, 2016 • Boston, MA



Targeting Membrane Proteins June 16-17, 2016 • Boston, MAChemical Biology in Drug DiscoveryJune 16-17, 2016 • Boston, MATumor Models for Cancer ImmunotherapyJune 16-17, 2016 • Boston, MA




Molecular Medicine Tri-ConferenceMarch 6-11, 2016 • San Francisco, CAAttracting over 3,300 drug discovery and development professionals from over 40 countries in 2015, the Tri-Conference has grown into a diverse event, focusing on Molecular Medicine, specifically on Discovery, Genomics, Diagnostics and Information Technology. With a 23 year history, this year’s expanded coverage includes additional programs on Molecular Diagnostics for Infectious Disease, Precision Medicine and Cancer Immunotherapy, as well as two new symposia on Companion Diagnostics and the Commercialization of Molecular Diagnostics.

TriConference.com

Biotherapeutics Analytical SummitMarch 14-18, 2016 • Bethesda, MDIn today’s competitive world of myriad biologics formats and the ever increasing regulatory demands, it is imperative for companies to come up with the best and fastest way to assess a molecule’s developability, develop the right assays, platforms and approaches, and ultimately establish a molecule’s comparability and/or biosimilarity to ensure regulatory success. At CHI’s 7th Annual Biotherapeutics Analytical Summit, we closely monitor these trends and are pleased to bring to you three timely and pertinent topics that will address Developability and Candidate Selection, Advances in Characterization Methods and Approaches, and Comparability and Biosimilarity.

BiotherapeuticsAnalyticalSummit.com

Cancer BiotherapeuticsMarch 14-16, 2016 • London, UKResearch in Cancer Biotherapeutics is progressing in leaps and bounds with rapid and exciting developments taking place with many different approaches. Cambridge Healthtech Institute, the producer of PepTalk and PEGS Protein & Antibody Engineering Summits, are responding by introducing a European event concentrating solely on this topic. Both tracks focus strongly on immunotherapy, with case studies on immune check point inhibitors, agonistic and immunomodulatory approaches, immunocytokines, chimeric antigen receptors, retargeting T cells, immunomodulatory bispecifics, oncolytic immunotherapy, and the role of dendritic cells. We also broaden the scope with presentations on targets and lead selection, fusion proteins, ADCs, and on recreating the tumour microenvironment for translational studies. For this inaugural event we have chosen central London, knowing that this will appeal to academics and industry experts. Our venue is right beside the river in Docklands, now a very modern and vibrant location.

CancerBiotherapeutics.com

Oligonucleotide Therapeutics and DeliveryApril 4-5, 2016 • Cambridge, MAOligonucleotide–based therapeutics have long formed the third major drug development platform, specifically focused on modulating gene expression by targeting RNA or the genome itself. A key distinguishing attribute of nucleic acids as therapeutic agents is their ability to access the “undruggable” space left by small molecules and biologics, allowing drug developers to address a wider range of diseases, and particularly those with limited or no therapeutic options. This has generated significant interest in this field; however, first generation molecules exhibiting potency and safety issues have hindered the potential of oligonucleotide therapies, dramatically impacting the drug development landscape. Recent advances in nucleic acid chemistry and delivery to improve stability, bioavailability, specificity and potency are now driving the rapid development and clinical evaluation of a new generation of therapies poised for success.

Healthtech.com/Oligonucleotide

microRNA as Biomarkers and DiagnosticsApril 4-5, 2016 • Cambridge, MARecent research has shown small, non-coding microRNAs to be master regulators of cellular processes, and expression patterns have revealed their potential as diagnostic, prognostic, and treatment response biomarkers. Cambridge Healthtech Institute’s Twelfth Annual microRNA as Biomarkers and Diagnostics meeting will cover the latest research in the use of microRNAs for early detection of disease, monitoring cancer progression and therapeutic response, and understanding immunity. Implications for the future of personalized medicine will also be discussed.

RNAconference.com/microRNA

Extracellular RNA in Drug and Diagnostic DevelopmentApril 5-6, 2016 • Cambridge, MAExtracellular RNAs (exRNAs) found in biofluids are a rich source of information about cellular processes in both health and disease. In particular, exRNAs enclosed in extracellular vesicles and therefore protected from degradation, are involved in intercellular communication and may serve as diagnostic and prognostic biomarkers of cancer, cardiovascular and neurodegenerative diseases. Cambridge Healthtech Institute’s Second Annual Extracellular RNA in Drug and Diagnostic Development meeting will present the latest research in this emerging area of non-invasive diagnostics, including exosomes and microvesicles, circulating microRNA and other non-coding RNA, and issues of standardization, profiling, and data analysis.

RNAconference.com/Extracellular-RNA

Conferences by Date with Detail

Conferences by SeriesTranslational Gene Editing June 16-17, 2016 • Boston, MA

The Liquid Biopsy Summit June 22-24, 2016 • San Francisco, CA

Continuous Processing in Biopharm Manufacturing August 15-16, 2016 • Boston, MA

Advances in Purification Technologies August 17-18, 2016 • Boston, MA

Enabling Point-of-Care Diagnostics August 23-24, 2016 • Washington, DC

Clinical NGS Assays August 23-24, 2016 • Washington, DC

Circulating Tumor Cells August 23-24, 2016 • Washington, DCDNA Forensics August 23-24, 2016 • Washington, DC

Clinical Application of Cell-Free DNA August 24-25, 2016 • Washington, DC

Leveraging Pharmacies for Rapid Diagnostics August 24-25, 2016 • Washington, DC

Telemedicine August 26, 2016 • Washington, DC



Medical Informatics WorldApril 4-5, 2016 • Boston, MANow in its fourth year, Medical Informatics World has become a must-attend industry event, uniting senior-level executives and industry leaders representing all the major contributors to a new era of healthcare. More than 400 providers, payers, technology vendors, biomedical scientists, academic researchers, informaticists and national health organizations come together to discuss emerging trends and collaborations in health IT for improved outcomes in the healthcare ecosystem. Focused tracks allow the community to delve into the most pressing topics of cross-industry data sharing, population health, patient engagement, and clinical decision support. Keeping pace with the evolving industry, coverage has now expanded to include quantitative imaging and radiomics, predictive analytics and interoperability.

MedicalInformaticsWorld.com

Bio-IT WorldApril 5-7, 2016 • Boston, MASince its debut in 2002, the Annual Bio-IT World Conference & Expo has established itself as a premier event showcasing the myriad of IT and informatics applications and enabling technologies that drive biomedical research, drug discovery & development, and clinical and healthcare initiatives. The Bio-IT World Conference & Expo continues to be a vibrant event that unites 3,000+ life sciences, pharmaceutical, clinical, healthcare, and IT professionals from more than 30 countries. Spanning three days, the 2016 meeting includes 13 parallel conference tracks and 16 pre-conference workshops. Compelling talks, including best practice case studies and joint partner presentations, will feature over 260 of your fellow industry and academic colleagues discussing themes of big data, smart data, cloud computing, trends in IT infrastructure, omics technologies, high-performance computing, data analytics, open source and precision medicine, from the research realm to the clinical arena.

Bio-ITWorldExpo.com

PEGS China SummitApril 5-7, 2016 • Shanghai, ChinaCompanies in China are increasingly being perceived as competitors and potential partners in novel biotherapeutics development. Local conglomerates are setting up biotherapeutic arms; multi-nationals are localizing research and development; innovative returnees are starting up new biotech ventures; and universities are spinning off novel ideas and training future generations in the protein sciences. All these are making China a futile fertile ground for the growth of novel biotherapeutics. In its third year, “PEGS China: Protein and Antibody Engineering & Development Summit” returns to Shanghai for 3 days of inspiring presentations and case studies featuring the latest trends and future potential of China’s biotech industry. This year’s event comprises four content-driven conferences with over sixty global speakers, plus a new seminar on clinical & regulatory strategies for global and domestic IND and BLA filings. In addition, dedicated exhibit hall and poster viewing hours will provide invaluable opportunities for networking, deal-making and ideas exchange.

PEGSummitChina.com

Molecular Diagnostics EuropeApril 4-7, 2016 • Lisboa, PortugalNovel molecular-based tools are rapidly entering the clinic and creating a new paradigm in healthcare. The Fourth International Molecular Diagnostics Europe event will return to Lisbon this spring and feature six tracks: Prenatal Molecular Diagnostics, Reproductive Genetic Diagnostics, Circulating Tumour Cells, Circulating Cell-Free DNA, Advanced Diagnostics for Infectious Disease, and Point-of-Care Diagnostics. As the prenatal diagnostics market has demonstrated, molecular diagnostics are being applied to the clinical setting for greater speed and accuracy of healthcare delivery, while paving the way for a new era in medicine.

MolecularDxEurope.com

Drug Discovery ChemistryApril 19-22, 2016 • San Diego, CADrug Discovery Chemistry is a dynamic conference for medicinal chemists working in pharma and biotech. Focused on discovery and optimization challenges of small molecule drug candidates, this event provides many exciting opportunities for scientists to create a unique program according to personal interests. New for 2016 will be the addition of three symposia on Friday covering the blood-brain barrier, biophysical approaches for drug discovery, and antivirals.

DrugDiscoveryChemistry.com

PEGS: The Essential Protein Engineering SummitApril 25-29, 2016 • Boston, MAWith record-breaking attendance in 2015, PEGS Boston attracts an international delegation of nearly 2,000 participants including conference delegates, speakers, exhibitors, sponsors and guests representing over 30 countries. Participants value the in-depth short courses, access to 22 conferences, and wide-ranging presentations delivering new unpublished data, case studies, innovation and insight. The vast exhibit hall will be packed with 125 exhibiting companies and more than 200 research posters on display providing valuable viewing of innovative new technologies, as well as abundant networking with biopharma researchers and industry representatives.

PEGSummit.com

Clinical Trial Innovation SummitMay 9-11, 2016 • Boston, MACambridge Healthtech Institute’s Fifth Annual Clinical Trial Innovation Summit will bring together leaders from across pharma, biotech and academia to share case studies and best practices on effective clinical trial management and vendor oversight. The 2016 program focuses on key issues and opportunities in the clinical trial industry, including Data Integration, Existing Data Sources, Mobile Tech, Project Management, Outsourcing, Vendor Management, Budgeting and Contracting, Quality (QbD) in Trial Conduct, Risk-Based Monitoring and Clinical Auditing.

ClinicalTrialSummit.com

Strategic Alliance Management CongressMay 16-18, 2016 • Philadelphia, PACambridge Healthtech Institute’s 13th Annual Strategic Alliance Management Congress brings together senior alliance management, business development, technology transfer and licensing professionals, to network, share experiences, discuss case studies, and to share the components that cultivate successful partnerships. Delegates will gain strategic insights, proven tools, methods, and perspectives from a variety of leaders advancing the art of alliance management.

Healthtech.com/Strategic-Alliance-Management-Congress


LIFE SCIENCE

MEDIALIBRARY

Continue Your Education with CHI’s Digital Courses

Navigate, pause, rewind and listen to recorded sessions in a multimedia presentation. Visit CHI’s Life Science Media Library to view over 120 digital courses recorded at our most successful events.

Formats available:Digital DownloadOn DemandDVD Healthtech.com/MediaLibrary

Order Today


Biomarkers & Diagnostics World CongressMay 17-19, 2016 • Philadelphia, PACambridge Healthtech Institute’s Twelfth Annual Biomarkers & Diagnostics World Congress 2016 is dedicated to all areas of biomarker research spanning the pharmaceutical and diagnostic pipeline. The meeting brings together a unique and international mix of large and medium pharmaceutical, biotech and diagnostics companies, leading universities and clinical research institutions, government and national labs, CROs, emerging companies and tool providers—making the Congress a perfect meeting-place to share experience, foster collaborations across industry and academia, and evaluate emerging technologies. Now in its twelfth year, the Biomarkers & Diagnostics World Congress is the leading annual meeting dedicated to biomarker and diagnostics research and implementation that consistently delivers a cutting-edge agenda, 400+ senior delegates, and a sold-out exhibit hall. The World Congress will continue offering comprehensive coverage of biomarkers, including translational biomarkers in drug discovery, patient selection biomarkers, strategies to co-develop drugs with companion diagnostics, cell-free DNA and RNA, as well as coverage of big data for personalized medicine. New additions this year will include a track on Biomarkers for Cancer Immunotherapy, as well as two pre-conference symposia, covering next-generation sequencing and exosomes.

BiomarkerWorldCongress.com

World Preclinical CongressJune 14-17, 2016 • Boston, MAIn recent years, the World Preclinical Congress (WPC) has turned into a key networking event for those involved in preclinical research. It features conferences, training seminars and short courses that cover the very latest in preclinical strategies and technologies, to enable better and faster decisions in drug discovery. WPC attracts a diverse, global audience, which include experts, as well as people who are new and eager to contribute to the field. Having chemists, biologists, pharmacologists, toxicologists, screening and formulation experts in attendance, creates an interesting cross-disciplinary environment for tackling challenges and sharing expertise. Now in its 15th year the event will continue to highlight ways to improve accuracy and efficiency in preclinical research, while bringing together the people and technologies to make it happen. As always, we ask those of you involved in preclinical work to try and help innovate traditional drug discovery by bringing along your ideas, showcasing new technologies, and fostering new collaborations. WPC is indeed the event “Where Preclinical Minds Meet Discovery Technologies” and we hope you can join this dynamic community to help shape the future of preclinical research!

WorldPreclinicalCongress.com

The Liquid Biopsy SummitJune 22-24, 2016 • San Francisco, CAThis is an unprecedented time in biomolecular medicine. Recent scientific findings have determined biofluids consist of circulating cell-free (cf)DNA and extracellular (ex)RNA from multiple tissues within the body. In addition, the rapid development of highly sensitive and accurate next-generation sequencing (NGS) technologies has empowered researchers to analyze the role of these biomolecules in health, disease and treatment response. However, there remains considerable insecurity associated with biofluid-based DNA/RNA analytical methods which must be solved before liquid biopsies can be implemented for broader routine applications. With refinements in the process and technology, molecular liquid biopsies have the potential to become a fulcrum in the future of precision medicine.

LiquidBiopsySummit.com

Biodefense World SummitJune 27-30, 2016 • Baltimore, MDThe Knowledge Foundation’s Second Annual Biodefense World Summit brings together leaders from government, academia, and industry for compelling discussions and comprehensive coverage on pathogen detection, sample prep technologies, point-of-care, and biosurveillance. Across the four-track event, attendees can expect exceptional networking opportunities in the exhibit hall, across panel discussions, and shared case studies with members of the biodefense community from technology providers to policy makers.

BiodefenseWorldSummit.com

The Bioprocessing SummitAugust 15-19, 2016 • Boston, MAThe Bioprocessing Summit brings together international leaders to discuss today’s bioprocess issues from cell line selection to bioproduction. The Summit provides practical details in a relaxed, congenial atmosphere that promotes information exchange and networking. This leading bioprocess meeting is hosted in Boston each summer along the lively and cosmopolitan harbor waterfront. Each year, the international bioprocessing community comes together at the Summit to share practical solutions for today’s bioprocess challenges with researchers from around the world. Spanning five days, the 2016 meeting includes 16 conference programs, 9 training seminars, and 10 short courses.

BioprocessingSummit.com

Next Generation Dx SummitAugust 23-26, 2016 • Washington, DCNext Generation Dx Summit convenes more than 1,000 international diagnostic professionals for valuable networking and comprehensive programming spanning from clinical diagnostics to business strategy. Now in its eighth year, the event has grown to include novel immunotherapy biomarkers, cell-free DNA, companion diagnostics, infectious disease, point-of-care, pharmacy-based diagnostics, commercialization, and reimbursement. New programming in 2016 includes prenatal diagnostics, circulating tumor cells, forensics, telemedicine and microbiome sequencing. The Next Generation Dx Summit is a must-attend event with complete coverage of the most timely and important issues for the industry.

NextGenerationDx.com

The Immuno-Oncology SummitAug. 24-Sept. 2, 2016 • Boston, MAAs our understanding of tumor immunology has advanced, immuno-oncology has made unprecedented progress in improving the outcomes for cancer patients. Still, with the field in its infancy, the full curative potential of IO has yet to be realized. CHI’s 4th Annual Immuno-Oncology Summit has been designed to support a coordinated effort by industry players to bring commercial immunotherapies and immunotherapy combinations through clinical development and into the market. This weeklong, nine-meeting set will include topics ranging from early discovery through clinical development as well as emerging areas such as oncolytic virotherapy. Overall, this event will provide a focused look at how researchers are applying new science and technology in the development of the next generation of effective and safe immunotherapies.

Immuno-OncologySummit.com



MOLECULAR MEDICINE TRI-CONFERENCE March 6-10, 2016 • San Francisco, CA

BIO-IT WORLDApril 5, 2016 • Boston, MA

-- Translating CTCs to Clinical Use -- Handling Troubled Projects

-- Microbiome: Sorting Out the Hype from the Hope -- Intelligent Methods Optimization of Algorithms for NGS

-- NGS Assay Selection, Validation and Compliance -- Visualization for Biomedical Data Analysis: From the Basics to Applications -- Sequencing 101

-- Through the Molecular Looking Glass of High-Resolution Melting -- Data Management for Biologics: Registration and Beyond

-- Reimbursement for Advanced Diagnostics: From Clinical Value Establishment to Coding, Coverage and Pricing

-- Security Considerations for Virtual Research

-- Opportunities and Challenges of Mobile Health, Wearables, and Sensors for Pharma -- Clinical Informatics: Returning Results from Big Data

-- Development of Bioassays for Checkpoint Immunotherapy -- Innovation and Patient-Centricity

-- Regulatory Compliance in Molecular Diagnostics -- Creating a Best of Breed Informatics Environment for your Organization -- Digital PCR: Applications and Advances

-- Liquid Biopsy Technologies Overview -- Growth Strategy: Leveraging Cloud Scalability to Enable Rapid Growth and Change -- Diagnostics Applications in Telemedicine

-- Commercialization Boot Camp: Manual for Success in Molecular Diagnostics

-- iConquerMS™: A Patient-Centered Research Model

-- Determining Genome Variation and Clinical Utility

-- Next-Generation Sequencing as a Diagnostics Platform -- Data Science Driving Better Informed Decisions

-- Isolation and Characterization of Cancer Stem Cells -- DNA for Data Storage

-- Translating Preclinical Data in the Rational Design of Cancer Combination Therapies

-- Designing Storage Solutions for Life Sciences

-- Best Practices in Personalized and Translational Medicine DRUG DISCOVERY CHEMISTRYApril 18-20, 2016 • San Diego, CA -- NGS for Infectious Disease Diagnostics

-- Metabolic Microbiome -- Trends in Physical Properties of Drugs

-- Detection and Characterization of Circulating Biomarkers -- GPCR Structure-Based Drug Discovery

-- A Primer to Gene Editing: Tools and Applications -- Designing Peptide Therapeutics for Specific PPIs

-- Immunology Basics for Chemists

CANCER BIOTHERAPEUTICSMarch 15, 2016 • London, UK

-- Phenotypic Screening and Chemical Probe Development

-- Crystallography for Drug Design

-- Cancer Immunotherapy -- Ligand-Receptor Molecular Interactions and Drug Design

-- Engineering and Optimisation of Antibody Products -- Inhibitor Design using MOE SBDD Applications

-- Enabling Macrocyclic Compounds for Drug Discovery: Opportunities, Challenges and StrategiesBIOTHERAPEUTICS ANALYTICAL SUMMIT

March 15, 2016 • Bethesda, MD -- Advancing Tools and Technologies for Fragment-Based Design

-- SVPs, Aggregates and Impurities: Measurement, Characterization, and Impact

-- Introduction to Targeted Covalent Inhibitors

-- Glycobiology of Antibodies PEGS BOSTONApril 24-29, 2016 • Boston, MA -- New Analytical Approaches & Strategies for Comparability and

Biosimilarity -- Fluorescent Proteins in Protein Engineering

-- Bioanalytical Considerations of Multi-Domain Biotherapeutics: Preclinical and Clinical DevelopmentOLIGONUCLEOTIDE THERAPEUTICS AND DELIVERY

April 3, 2016 • Cambridge, MA -- Antibody Humanization via One Hot Homology Model Workshop

-- Oligonucleotide Therapeutics: From Discovery to Manufacturing -- Translational Considerations for Development of Monoclonal Antibodies: Focus on Early Discovery (Part I)

MICRORNA AS BIOMARKERS & DIAGNOSTICS

EXTRACELLULAR RNA IN DRUG & DIAGNOSTIC DEVELOPMENTApril 3-5, 2016 • Cambridge, MA

-- Immunogenicity Risk Assessment and Regulatory Strategies

-- In silico Immunogenicity Predictions Workshop

-- Translational Considerations for Development of Monoclonal Antibodies: Focus on Nonclinical Development to Clinic (Part II) -- Data Normalization Challenges and Solutions

-- microRNA-Based Therapeutics -- Next-Generation Sequencing of Antibody Libraries: Details on Experimental and Bioinformatic Methods -- microRNAs in the Immune Response

Short Course Schedule HOLD A COURSE AT YOUR FACILITY.For more information, please contact Edel O’Regan at 781-972-5423 or email: [email protected]


PEGS BOSTON (CONTINUED) THE LIQUID BIOPSY SUMMIT

-- Overcoming the Challenges of Immunogenicity Assessment June 22-24 2016 • San Francisco, CA -- Analyzing and Rationalizing Protein-Protein Interactions -- Course Title TBA -- Clinical Prospects of Cancer Immunotherapy

-- Strategic Bioassay Design and Analysis THE BIOPROCESSING SUMMIT

-- Critical Considerations for the Design and Development of Antibody-Drug Conjugates

August 15-18, 2016 • Boston, MA

-- Optimizing Media – Achieving Super Soup

-- Accelerated Stability Testing of Biologics

CLINICAL TRIAL INNOVATION SUMMITMay 9-11, 2016 • Boston, MA

-- Analytical Strategies for Comparability in Bioprocess Development

-- Course Title TBA -- Operational Excellence Strategies for Bioprocessing - QbD, DoE, and PAT -- Course Title TBA

-- Course Title TBA -- Protein Aggregation: Mechanism, Characterization and Consequences

STRATEGIC ALLIANCE MANAGEMENT CONGRESSMay 16, 2016 • Philadelphia, PA

-- Transient Protein Production in Mammalian Cells

-- The Key Skills of the Alliance Manager: Models, TooIs NEXT GENERATION DX SUMMIT

and Frameworks for Maximum Impact August 22-24, 2016 • Washington, DC

-- Use of FFPE/Fixed Tissues for Clinical Research

BIOMARKERS & DIAGNOSTICS WORLD CONGRESSMay 16-18, 2016 • Philadelphia, PA

-- Method Validation According to CLSI Guidelines

-- Practical Considerations for NGS Data Analysis and Interpretation

-- Fit-for-Purpose Biomarker Assay Development and Validation -- Microfluidics for Point-of-Care

-- Circulating Tumor Cells: Biomarkers for Personalized Oncology -- Establishing the Value of Diagnostic Tests

-- ThinkTank: PD-L1 Assays for Biomarkers and Companion Diagnostics

-- NGS as a Diagnostics Platform

-- Detection and Characterization of Circulating Biomarkers

-- Regulatory Compliance in Molecular Diagnostics

WORLD PRECLINICAL CONGRESSJune 14-16, 2016 • Boston, MA

-- Use of CLIA-Waived Point-of-Care and Rapid Diagnostics Tests in Community Pharmacies

-- Immunosequencing: Generating a New Class of Cancer Immunotherapy Diagnostics

-- Regulatory and Reimbursement Considerations with NGS and Other Multiplex Assays

-- Drug Metabolism and Its Impact on Decisions in Lead Discovery - Part One

-- Drug Metabolism and Its Impact on Decisions in Drug Development - Part Two

-- Modern Lead Generation Strategies - Part One

-- Convergence of Immunotherapy and Epigenetics for Cancer Treatment

-- Strategies for Patenting Checkpoint Inhibitor Antibody Cancer Therapies

-- Modern Lead Generation Strategies - Part Two

-- Rational Design of Cancer Combination Therapies

-- How to Best Utilize Organotypic 3D Cell Culture Assays in Oncology

-- Molecular Imaging of the Blood-Brain Barrier

-- Immunocompetent Murine Models for Preclinical Assessment of Cancer Immunotherapy

-- 3D Bioprinting

-- A Primer to Gene Editing: Tools and Applications

-- Importance of Solubility in Drug Discovery and Development

Short Course Schedule

CHI is a division of Cambridge Innovation Institute

CHI

Cambridge Healthtech Institute (CHI) is the preeminent life science network for leading researchers and business experts from top pharmaceutical, biotech, CROs, academia, and niche service providers. CHI is renowned for its vast conference portfolio held worldwide including PepTalk, Molecular Medicine Tri-CON, SCOPE Summit, Bio-IT World Conference & Expo, PEGS Summit, Drug Discovery Chemistry, Biomarker World Congress, World Pharmaceutical Congress, Next Generation Dx Summit and Discovery on Target.

About Cambridge Healthtech InstituteYour Life Science Network

ADDITIONAL DIVISIONS OF CHI INCLUDE

healthtechpublishing.com insightpharmareports.com

knowledgefoundation.com barnettinternational.com

healthtech.com250 First Avenue, Suite 300

Needham, Massachusetts 02494

USA Phone: 781.972.5400

Documents

Cambridge - Healthtech › uploadedFiles › Conferences › CHI-Catalog...WORLD CONGRESS & May 17-19, 2016 Philadelphia Downtown Marriott Philadelphia, PA BiomarkerWorldCongress.com